Position in VRTX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$104,258,157
-$14,548,003 QoQ
Shares Held
233,480
-10.9% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,721,223,490 across 84 Biotechnology names. VRTX ranks #1 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 4 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 5 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 | |
| 8 | SRPT |
Sarepta Therapeutics, Inc.
|
2,318,890 | $50,459,046 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $104,258,157 | 233,480 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $118,806,160 | 262,057 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $123,323,126 | 314,889 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $128,202,907 | 287,967 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $147,731,440 | 304,714 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $139,966,438 | 347,570 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $172,586,071 | 371,089 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $174,083,544 | 371,402 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $240,020,087 | 574,197 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $236,410,412 | 581,018 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $68,257,188 | 196,288 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $69,370,257 | 197,125 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $62,662,695 | 198,885 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $53,082,382 | 183,816 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $54,090,414 | 186,815 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $29,862,412 | 105,974 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $25,153,069 | 96,383 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $20,779,209 | 94,623 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $93,386,644 | 514,839 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $106,347,523 | 527,439 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $20,871,835 | 97,128 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $21,337,483 | 90,283 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $23,706,549 | 87,118 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $28,892,810 | 99,524 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $24,050,318 | 101,073 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||